Clinical Trials Browser

Phase 3 × NIH × Dalteparin × Clear all

NCT00519805 2011-08-08

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thromboembolism